Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment

This is a prospective observational cohort study (AI-Kidney-Prognosis), aiming to non-invasively predict the clinical outcomes in renal cell carcinoma patients after surgical treatment using radiomics-based AI models, thereby assisting clinical decision-making and personalized follow-up strategies.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Renal Cell Carcinoma (Kidney Cancer) Adenocarcinoma Carcinoma Carcinoma, Renal Cell Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Kidney Neoplasms Male Urogenital Diseases Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Union Hospital，Tongji Medical College，Huazhong University of Science and Technology

Wuhan, Hubei, 430000, China

Location status: Recruiting

Location contact

Lian Yang

CONTACT

[email protected]

18986273791

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients were treated for renal cell carcinoma in Wuhan Union Hospital from August 2025 to August 2026;
Aged > 18 years old;
At least one abdominal CT scan before treatment;
Tissue biopsy pathological examination confirmed the diagnosis of renal cell carcinoma.

Exclusion criteria

Poor image quality;
Incomplete clinical data or loss of follow-up;
Presence of another primary malignancy other than renal cell carcinoma;
Unclear pathological diagnosis.

Treatment and study plan

Primary outcomes

Progression-free survival

Time frame: 1 year

Study contacts

Contact information is provided by the study sponsor or research team.

Lian Yang

CONTACT

[email protected]

18986273791

Sponsors and collaborators

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Other

Registry information

Official study title

Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment (AI-Kidney-Prognosis)

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Aug 12, 2025
Registry last updated: Aug 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting